A Promising Path Forward in Obesity Pharmacotherapy: Ecnoglutide and the Evolution of GLP-1R Agonist Design Announcing a new article publication for BIO Integration journal.  This article reviews robust evidence from a large, multicenter, randomized, placebo-controlled study in Chinese adults with overweigh...

A randomized clinical trial exploring the efficacy of #ecnoglutide, a novel cyclic #adenosine #monophosphate (cAMP)-biased #GLP-1RA, in #obesity without diabetes.

#OpenAccess: bio-integration.org/glp1ra-ecnog...